AzTrials
AzTrials

Correlation Between Serum Chloride and Anion Gap in DKA PatientsNCT05598866

Correlation Between Serum Chloride and Anion Gap Levels in DKA Patients

An observational study of Correlation Between Serum Chloride and Anion Gap in DKA Patients, run by Mervat Mokhles Fathi Sayed at 1 site in Egypt.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

2.2 Aim(s) of the Research (50 words max): 1. To examine the description and correlation of changes in the serum chloride levels and changes in the anion gap values before and after fluid resuscitation in patients with DKA and to examine the description and correlation of changes in the serum chloride. 2. Read more about this study

Who is it for?
Ages 15 to 70 years
How many people
54 participants
Where
1 siteEgypt
Study dates
Oct 2022to Oct 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 15 to 70 years
  • All sexes
  • Child, Adult, Older adult

Study population: any patients admitted to intensive care unit, critical care unit in Assuit university from……to…….. * Blood glucose level >250 mg/dl ( normal 70-100) * Ph<7.3 ( normal PH 7.35- 7.45) * Hco3<15 m mol/litre ( normal HCO3 22-26) * Serum chloride before resucitation <107m mol/litre (normal 96- 106) * Urea <6.5 m mol/litre * S.create <120 m mol/litre

Who may be able to join

  • any patients admitted to intensive care unit, critical care unit in Assuit university from 15 yrs to 70
  • Blood glucose level >250 mg/dl ( normal 70-100)
  • Ph<7.3 ( normal PH 7.35- 7.45)Hco3<15 m mol/litre ( normal HCO3 22-26)
  • Serum chloride before resucitation <107m mol/litre (normal 96- 106)
  • Urea <6.5 m mol/litre
  • S.create <120 m mol/litre

Who cannot join

  • Patients receiving chemotherapy, diuretics, corticosteroids, laxatives
  • Patients diagnosed to have Addison disease
  • Patients with chronic kidney disease and acute kidney injury, end stage renal disease, renal tubular acidosis
  • Patients with malabsorpion syndrome ( celiac disease, crohn's , celiac disease )
  • Patients with chronic respiratory acidosis (asthma, COPD, pulmonary fibrosis, neuromuscular disorders)
  • Patients with diarrhea

Trial locations and contacts

1 site in 1 country.

Mervat Mokhles Fathy contact

01002488659

Mokhlesmervat@gmail.com

Mokhles Fathy Sayed contact

01007846510

Egypt1 site
  • Assiut university hospitals

    Asyut

    Assiut Hospitals, Master

Other trials in Egypt

About this study

Official title: Correlation Between the Serum Chloride Levels and the Anion Gap Values in the Initial Fluid Resuscitation in DKA Patients and Its Relation to Outcome

2.2 Aim(s) of the Research (50 words max):

  1. To examine the description and correlation of changes in the serum chloride levels and changes in the anion gap values before and after fluid resuscitation in patients with DKA and to examine the description and correlation of changes in the serum chloride.
  2. relation of serum chloride and outcome in patients with DKA
Read the detailed description

Diabetic ketoacidosis (DKA) is one of the most serious and acute complications of diabetes. DKA is a significant contributor to mortality, costs, and poor quality of life.

The total incidence of DKA tends to increase, mainly due to an increase in type 2 diabetes cases and obesity.

DKA consists of the biochemical triad of hyperglycemia, ketonemia, and metabolic acidosis resulting from absolute or relative insulin deficiency and an increase in counter-regulatory hormones. These life-threatening consequences produce severe body water deficit, the accumulation of ketone bodies, and electrolyte disturbances.

Hyperglycemia develops because of three processes: increased gluconeogenesis, accelerated glycogenolysis, and impaired glucose utilization by peripheral tissues. The hyperglycemia will lead to glycosuria and osmotic diuresis, resulting in hyperosmolar intracellular dehydration.

In DKA, fluid deficits may be up to 10% of total body weight and electrolyte deficits in the body, one of which is chloride.

In DKA, lipolysis resulting in high circulating levels of free fatty acids may occur. These free fatty acids are taken up by the liver and oxidized to ketone bodies. Excessive production of ketone bodies in the anionic form can cause high plasma anion gap. Ketone bodies are relatively strong acids that dissociate at physiologic pH. The dissociation in the form of H+ ions will be buffered by bicarbonate. When the plasma bicarbonate concentrations decrease, a high anion gap acidosis metabolic (HAGMA) develops. The anion gap calculation formula is [Na+ (Cl-+ HCO3)]. Based on diagnostic criteria, the anion gap value in DKA >10. The increased anion gap is a predictor of metabolic acidosis, and the degree of metabolic acidosis can be estimated by the size of the anion gap. Initial management of adult patients with DKA is rehydration with normal saline fluid (0.9% NaCl) intravenously and insulin administration (when the serum potassium levels <3.3 mEq/L). The initial dose of normal saline infusion is 15-20 mL/kg/hour over the first hour.

Subsequent amount of fluid given depends on the hydration status, hemodynamic conditions, and electrolyte levels. Electrolyte levels are monitored after 2 hours of initial fluid resuscitation.

The goals of rapid rehydration are to improve the circulatory volume and tissue perfusion, clear ketone bodies, and correct electrolyte imbalances. Normal saline contains 154 mEq/L chloride and 154 mEq/L sodium.

The chloride concentration of saline is higher than that of human plasma (97-107 mEq/L).

Normal saline (0.9% sodium chloride) is a low-cost and easy-to-find crystalloid fluid which becomes fluid choice by doctors in some cases. However, normal saline is now under observation due to concerns about hyperchloremic metabolic acidosis, oliguria, prolonged acidosis, and coagulopathy. Consistent data are found regarding increased serum chloride levels associated with complications of acidosis, AKI, or electrolyte disturbances after being given at least 2 liters of normal saline. An increase in the chloride levels is not counterbalanced by an increase in the bicarbonate ion concentrations in plasma. Although the anion gap values decrease, acidosis still occurs. Thus, normal anion gap metabolic acidosis (NAGMA) or hyperchloremic acidosis arises.

Blood glucose level <200 mg/dL, serum bicarbonate level >15 mEq/L, pH >7.3, and normal anion gap are recovery signs of DKA.12 causes of hyperchloremia include: Gastrointestinal problems, such as vomiting or diarrhea. heat exposure, Diabetes insipidus, Some medications, particularly hormones as estrogens, diuretics, corticosteroids,and certain,chemotherapy Starvation due to eating disorders, severe malnourishment, or problems absorbing nutrients from food.

Addison's disease, diabetes insipidus,burns, kidney disease, kidney failure, and renal tubular acidosis

Hypochloremia can be caused by:

Diarrhea Vomiting Excessive sweating Kidney problems Chronic respiratory acidosis, Syndrome of inappropriate antidiuretic hormone excretion (SIADH), Metabolic alkalosis, Use of certain medications like corticosteroids, diuretics, laxatives, and bicarbonates

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. 1-Change in serum chloride levels before and after fluid resucitation in DKA patients. 2- change in anion gap level before and after fluid resuscitation in DKA patients.

    1. change in serum chloride level before and after fluid resuscitation in DKA patients.
    2. change in anion gap level before and after fluid resuscitation in DKA patients.

    Measured: 2 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Oct 2022
  2. Study startOct 2022 (estimated)
  3. Primary completionOct 2023 (estimated)
  4. Study completionOct 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
54 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05598866
Sponsor's protocol ID
Serum chloride in DKA
Status last verified
Oct 2022
First submitted
19 Aug 2022
Last updated
28 Oct 2022
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Correlation Between Serum Chloride and Anion Gap in DKA Patients, run by Mervat Mokhles Fathi Sayed at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 28 Oct 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Mervat Mokhles Fathy (01002488659, Mokhlesmervat@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

1-Change in serum chloride levels before and after fluid resucitation in DKA patients. 2- change in anion gap level before and after fluid resuscitation in DKA patients. (time frame: 2 years). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Oct 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in